http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102400464-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102400464-B1 |
| titleOfInvention | Biomarker composition for detecting cancer stem cell |
| abstract | The present invention relates to a biomarker for detecting cancer stem cells, and more particularly, a biomarker composition for detecting cancer stem cells using phosphatidylethanolamine (PE) expressed in cancer stem cells, a composition for cancer diagnosis, a cancer diagnosis kit and to a method of providing information on cancer diagnosis. It was confirmed that the expression of phosphatidylethanolamine, a biomarker for cancer stem cell detection according to the present invention, is significantly higher in cancer stem cells than in cancer cells and other cells, and is exposed to the outside of the cell membrane when expressed. This means that cancer stem cells can be more sensitively and accurately detected when the biomarker for cancer stem cell detection of the present invention is used. there is. |
| priorityDate | 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.